Roche Has Many Suitors For $1.4 Bil. OTC Unit
This article was originally published in The Tan Sheet
Executive Summary
A GlaxoSmithKline/Roche consumer unit combination would have approximately $7.56 bil. in annual sales
You may also be interested in...
Roche Could Have Buyer For OTC Unit By Early Summer
Potential suitors for Roche's consumer health unit will lay out their strategy for the business next month as the divestiture process of the OTC division picks up speed
Roche Could Have Buyer For OTC Unit By Early Summer
Potential suitors for Roche's consumer health unit will lay out their strategy for the business next month as the divestiture process of the OTC division picks up speed
Roche Could Have Buyer For OTC Unit By Early Summer
Potential suitors for Roche's consumer health unit will lay out their strategy for the business next month as the divestiture process of the OTC division picks up speed